ArticleFrontiers in immunology2023

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer.

Dongna Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.